BioStem Technologies (OTCMKTS:BSEM - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.31, Zacks reports. The company had revenue of $10.29 million during the quarter, compared to analyst estimates of $86.69 million.
BioStem Technologies Stock Performance
Shares of OTCMKTS:BSEM traded down $0.48 during trading on Friday, reaching $12.25. 96,304 shares of the stock were exchanged, compared to its average volume of 66,340. The firm's 50-day moving average price is $11.31 and its 200 day moving average price is $13.74. The firm has a market cap of $204.61 million, a price-to-earnings ratio of 18.01 and a beta of 0.09. BioStem Technologies has a 12-month low of $6.77 and a 12-month high of $28.26.
BioStem Technologies Company Profile
(
Get Free Report)
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Read More
Before you consider BioStem Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.
While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
